Disease-Modifying Antirheumatic Drug Market, Global Outlook and Forecast 2022-2028
It refers to drugs that can treat rheumatism, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, etc.
This report contains market size and forecasts of Disease-Modifying Antirheumatic Drug in global, including the following market information:
Global Disease-Modifying Antirheumatic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Disease-Modifying Antirheumatic Drug Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Disease-Modifying Antirheumatic Drug companies in 2021 (%)
The global Disease-Modifying Antirheumatic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-Steroidal Anti-Inflammatory Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Disease-Modifying Antirheumatic Drug include AbbVie, Amgen, Pfizer, Roche Holding AG, Novartis International AG, Johnson & Johnson, Bristol-Myers Squibb, Merck and UCB S.A. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Disease-Modifying Antirheumatic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Disease-Modifying Antirheumatic Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Disease-Modifying Antirheumatic Drug Market Segment Percentages, by Type, 2021 (%)
Global Disease-Modifying Antirheumatic Drug Market Segment Percentages, by Application, 2021 (%)
Global Disease-Modifying Antirheumatic Drug Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Disease-Modifying Antirheumatic Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Disease-Modifying Antirheumatic Drug revenues share in global market, 2021 (%)
Key companies Disease-Modifying Antirheumatic Drug sales in global market, 2017-2022 (Estimated), (MT)
Key companies Disease-Modifying Antirheumatic Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Disease-Modifying Antirheumatic Drug in global, including the following market information:
Global Disease-Modifying Antirheumatic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Disease-Modifying Antirheumatic Drug Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Disease-Modifying Antirheumatic Drug companies in 2021 (%)
The global Disease-Modifying Antirheumatic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-Steroidal Anti-Inflammatory Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Disease-Modifying Antirheumatic Drug include AbbVie, Amgen, Pfizer, Roche Holding AG, Novartis International AG, Johnson & Johnson, Bristol-Myers Squibb, Merck and UCB S.A. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Disease-Modifying Antirheumatic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Disease-Modifying Antirheumatic Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Disease-Modifying Antirheumatic Drug Market Segment Percentages, by Type, 2021 (%)
- Non-Steroidal Anti-Inflammatory Drugs
- Steroidal Anti-Inflammatory Drugs
- Slow Acting Drug
- Immunological Preparation
Global Disease-Modifying Antirheumatic Drug Market Segment Percentages, by Application, 2021 (%)
- Pharmaceutical Industry
- Hospital and Clinic
- Other
Global Disease-Modifying Antirheumatic Drug Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Disease-Modifying Antirheumatic Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Disease-Modifying Antirheumatic Drug revenues share in global market, 2021 (%)
Key companies Disease-Modifying Antirheumatic Drug sales in global market, 2017-2022 (Estimated), (MT)
Key companies Disease-Modifying Antirheumatic Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie
- Amgen
- Pfizer
- Roche Holding AG
- Novartis International AG
- Johnson & Johnson
- Bristol-Myers Squibb
- Merck
- UCB S.A.
- Eli Lilly and Company
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Disease-Modifying Antirheumatic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Disease-Modifying Antirheumatic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DISEASE-MODIFYING ANTIRHEUMATIC DRUG OVERALL MARKET SIZE
2.1 Global Disease-Modifying Antirheumatic Drug Market Size: 2021 VS 2028
2.2 Global Disease-Modifying Antirheumatic Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Disease-Modifying Antirheumatic Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Disease-Modifying Antirheumatic Drug Players in Global Market
3.2 Top Global Disease-Modifying Antirheumatic Drug Companies Ranked by Revenue
3.3 Global Disease-Modifying Antirheumatic Drug Revenue by Companies
3.4 Global Disease-Modifying Antirheumatic Drug Sales by Companies
3.5 Global Disease-Modifying Antirheumatic Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Disease-Modifying Antirheumatic Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Disease-Modifying Antirheumatic Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Disease-Modifying Antirheumatic Drug Players in Global Market
3.8.1 List of Global Tier 1 Disease-Modifying Antirheumatic Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Disease-Modifying Antirheumatic Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Disease-Modifying Antirheumatic Drug Market Size Markets, 2021 & 2028
4.1.2 Non-Steroidal Anti-Inflammatory Drugs
4.1.3 Steroidal Anti-Inflammatory Drugs
4.1.4 Slow Acting Drug
4.1.5 Immunological Preparation
4.2 By Type - Global Disease-Modifying Antirheumatic Drug Revenue & Forecasts
4.2.1 By Type - Global Disease-Modifying Antirheumatic Drug Revenue, 2017-2022
4.2.2 By Type - Global Disease-Modifying Antirheumatic Drug Revenue, 2023-2028
4.2.3 By Type - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Disease-Modifying Antirheumatic Drug Sales & Forecasts
4.3.1 By Type - Global Disease-Modifying Antirheumatic Drug Sales, 2017-2022
4.3.2 By Type - Global Disease-Modifying Antirheumatic Drug Sales, 2023-2028
4.3.3 By Type - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
4.4 By Type - Global Disease-Modifying Antirheumatic Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Disease-Modifying Antirheumatic Drug Market Size, 2021 & 2028
5.1.2 Pharmaceutical Industry
5.1.3 Hospital and Clinic
5.1.4 Other
5.2 By Application - Global Disease-Modifying Antirheumatic Drug Revenue & Forecasts
5.2.1 By Application - Global Disease-Modifying Antirheumatic Drug Revenue, 2017-2022
5.2.2 By Application - Global Disease-Modifying Antirheumatic Drug Revenue, 2023-2028
5.2.3 By Application - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Disease-Modifying Antirheumatic Drug Sales & Forecasts
5.3.1 By Application - Global Disease-Modifying Antirheumatic Drug Sales, 2017-2022
5.3.2 By Application - Global Disease-Modifying Antirheumatic Drug Sales, 2023-2028
5.3.3 By Application - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
5.4 By Application - Global Disease-Modifying Antirheumatic Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Disease-Modifying Antirheumatic Drug Market Size, 2021 & 2028
6.2 By Region - Global Disease-Modifying Antirheumatic Drug Revenue & Forecasts
6.2.1 By Region - Global Disease-Modifying Antirheumatic Drug Revenue, 2017-2022
6.2.2 By Region - Global Disease-Modifying Antirheumatic Drug Revenue, 2023-2028
6.2.3 By Region - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Disease-Modifying Antirheumatic Drug Sales & Forecasts
6.3.1 By Region - Global Disease-Modifying Antirheumatic Drug Sales, 2017-2022
6.3.2 By Region - Global Disease-Modifying Antirheumatic Drug Sales, 2023-2028
6.3.3 By Region - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Disease-Modifying Antirheumatic Drug Revenue, 2017-2028
6.4.2 By Country - North America Disease-Modifying Antirheumatic Drug Sales, 2017-2028
6.4.3 US Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.4.4 Canada Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.4.5 Mexico Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Disease-Modifying Antirheumatic Drug Revenue, 2017-2028
6.5.2 By Country - Europe Disease-Modifying Antirheumatic Drug Sales, 2017-2028
6.5.3 Germany Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.4 France Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.5 U.K. Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.6 Italy Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.7 Russia Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.8 Nordic Countries Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.9 Benelux Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Disease-Modifying Antirheumatic Drug Revenue, 2017-2028
6.6.2 By Region - Asia Disease-Modifying Antirheumatic Drug Sales, 2017-2028
6.6.3 China Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.6.4 Japan Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.6.5 South Korea Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.6.6 Southeast Asia Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.6.7 India Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Disease-Modifying Antirheumatic Drug Revenue, 2017-2028
6.7.2 By Country - South America Disease-Modifying Antirheumatic Drug Sales, 2017-2028
6.7.3 Brazil Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.7.4 Argentina Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Sales, 2017-2028
6.8.3 Turkey Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.8.4 Israel Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.8.6 UAE Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Disease-Modifying Antirheumatic Drug Major Product Offerings
7.1.4 AbbVie Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.1.5 AbbVie Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Disease-Modifying Antirheumatic Drug Major Product Offerings
7.2.4 Amgen Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.2.5 Amgen Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Disease-Modifying Antirheumatic Drug Major Product Offerings
7.3.4 Pfizer Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Roche Holding AG
7.4.1 Roche Holding AG Corporate Summary
7.4.2 Roche Holding AG Business Overview
7.4.3 Roche Holding AG Disease-Modifying Antirheumatic Drug Major Product Offerings
7.4.4 Roche Holding AG Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.4.5 Roche Holding AG Key News
7.5 Novartis International AG
7.5.1 Novartis International AG Corporate Summary
7.5.2 Novartis International AG Business Overview
7.5.3 Novartis International AG Disease-Modifying Antirheumatic Drug Major Product Offerings
7.5.4 Novartis International AG Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.5.5 Novartis International AG Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Disease-Modifying Antirheumatic Drug Major Product Offerings
7.6.4 Johnson & Johnson Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Corporate Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Major Product Offerings
7.7.4 Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.7.5 Bristol-Myers Squibb Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Disease-Modifying Antirheumatic Drug Major Product Offerings
7.8.4 Merck Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.8.5 Merck Key News
7.9 UCB S.A.
7.9.1 UCB S.A. Corporate Summary
7.9.2 UCB S.A. Business Overview
7.9.3 UCB S.A. Disease-Modifying Antirheumatic Drug Major Product Offerings
7.9.4 UCB S.A. Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.9.5 UCB S.A. Key News
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Corporate Summary
7.10.2 Eli Lilly and Company Business Overview
7.10.3 Eli Lilly and Company Disease-Modifying Antirheumatic Drug Major Product Offerings
7.10.4 Eli Lilly and Company Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.10.5 Eli Lilly and Company Key News
8 GLOBAL DISEASE-MODIFYING ANTIRHEUMATIC DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global Disease-Modifying Antirheumatic Drug Production Capacity, 2017-2028
8.2 Disease-Modifying Antirheumatic Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Disease-Modifying Antirheumatic Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DISEASE-MODIFYING ANTIRHEUMATIC DRUG SUPPLY CHAIN ANALYSIS
10.1 Disease-Modifying Antirheumatic Drug Industry Value Chain
10.2 Disease-Modifying Antirheumatic Drug Upstream Market
10.3 Disease-Modifying Antirheumatic Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Disease-Modifying Antirheumatic Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Disease-Modifying Antirheumatic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Disease-Modifying Antirheumatic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DISEASE-MODIFYING ANTIRHEUMATIC DRUG OVERALL MARKET SIZE
2.1 Global Disease-Modifying Antirheumatic Drug Market Size: 2021 VS 2028
2.2 Global Disease-Modifying Antirheumatic Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Disease-Modifying Antirheumatic Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Disease-Modifying Antirheumatic Drug Players in Global Market
3.2 Top Global Disease-Modifying Antirheumatic Drug Companies Ranked by Revenue
3.3 Global Disease-Modifying Antirheumatic Drug Revenue by Companies
3.4 Global Disease-Modifying Antirheumatic Drug Sales by Companies
3.5 Global Disease-Modifying Antirheumatic Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Disease-Modifying Antirheumatic Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Disease-Modifying Antirheumatic Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Disease-Modifying Antirheumatic Drug Players in Global Market
3.8.1 List of Global Tier 1 Disease-Modifying Antirheumatic Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Disease-Modifying Antirheumatic Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Disease-Modifying Antirheumatic Drug Market Size Markets, 2021 & 2028
4.1.2 Non-Steroidal Anti-Inflammatory Drugs
4.1.3 Steroidal Anti-Inflammatory Drugs
4.1.4 Slow Acting Drug
4.1.5 Immunological Preparation
4.2 By Type - Global Disease-Modifying Antirheumatic Drug Revenue & Forecasts
4.2.1 By Type - Global Disease-Modifying Antirheumatic Drug Revenue, 2017-2022
4.2.2 By Type - Global Disease-Modifying Antirheumatic Drug Revenue, 2023-2028
4.2.3 By Type - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Disease-Modifying Antirheumatic Drug Sales & Forecasts
4.3.1 By Type - Global Disease-Modifying Antirheumatic Drug Sales, 2017-2022
4.3.2 By Type - Global Disease-Modifying Antirheumatic Drug Sales, 2023-2028
4.3.3 By Type - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
4.4 By Type - Global Disease-Modifying Antirheumatic Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Disease-Modifying Antirheumatic Drug Market Size, 2021 & 2028
5.1.2 Pharmaceutical Industry
5.1.3 Hospital and Clinic
5.1.4 Other
5.2 By Application - Global Disease-Modifying Antirheumatic Drug Revenue & Forecasts
5.2.1 By Application - Global Disease-Modifying Antirheumatic Drug Revenue, 2017-2022
5.2.2 By Application - Global Disease-Modifying Antirheumatic Drug Revenue, 2023-2028
5.2.3 By Application - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Disease-Modifying Antirheumatic Drug Sales & Forecasts
5.3.1 By Application - Global Disease-Modifying Antirheumatic Drug Sales, 2017-2022
5.3.2 By Application - Global Disease-Modifying Antirheumatic Drug Sales, 2023-2028
5.3.3 By Application - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
5.4 By Application - Global Disease-Modifying Antirheumatic Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Disease-Modifying Antirheumatic Drug Market Size, 2021 & 2028
6.2 By Region - Global Disease-Modifying Antirheumatic Drug Revenue & Forecasts
6.2.1 By Region - Global Disease-Modifying Antirheumatic Drug Revenue, 2017-2022
6.2.2 By Region - Global Disease-Modifying Antirheumatic Drug Revenue, 2023-2028
6.2.3 By Region - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Disease-Modifying Antirheumatic Drug Sales & Forecasts
6.3.1 By Region - Global Disease-Modifying Antirheumatic Drug Sales, 2017-2022
6.3.2 By Region - Global Disease-Modifying Antirheumatic Drug Sales, 2023-2028
6.3.3 By Region - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Disease-Modifying Antirheumatic Drug Revenue, 2017-2028
6.4.2 By Country - North America Disease-Modifying Antirheumatic Drug Sales, 2017-2028
6.4.3 US Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.4.4 Canada Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.4.5 Mexico Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Disease-Modifying Antirheumatic Drug Revenue, 2017-2028
6.5.2 By Country - Europe Disease-Modifying Antirheumatic Drug Sales, 2017-2028
6.5.3 Germany Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.4 France Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.5 U.K. Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.6 Italy Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.7 Russia Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.8 Nordic Countries Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.5.9 Benelux Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Disease-Modifying Antirheumatic Drug Revenue, 2017-2028
6.6.2 By Region - Asia Disease-Modifying Antirheumatic Drug Sales, 2017-2028
6.6.3 China Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.6.4 Japan Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.6.5 South Korea Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.6.6 Southeast Asia Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.6.7 India Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Disease-Modifying Antirheumatic Drug Revenue, 2017-2028
6.7.2 By Country - South America Disease-Modifying Antirheumatic Drug Sales, 2017-2028
6.7.3 Brazil Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.7.4 Argentina Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Sales, 2017-2028
6.8.3 Turkey Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.8.4 Israel Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
6.8.6 UAE Disease-Modifying Antirheumatic Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Disease-Modifying Antirheumatic Drug Major Product Offerings
7.1.4 AbbVie Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.1.5 AbbVie Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Disease-Modifying Antirheumatic Drug Major Product Offerings
7.2.4 Amgen Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.2.5 Amgen Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Disease-Modifying Antirheumatic Drug Major Product Offerings
7.3.4 Pfizer Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Roche Holding AG
7.4.1 Roche Holding AG Corporate Summary
7.4.2 Roche Holding AG Business Overview
7.4.3 Roche Holding AG Disease-Modifying Antirheumatic Drug Major Product Offerings
7.4.4 Roche Holding AG Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.4.5 Roche Holding AG Key News
7.5 Novartis International AG
7.5.1 Novartis International AG Corporate Summary
7.5.2 Novartis International AG Business Overview
7.5.3 Novartis International AG Disease-Modifying Antirheumatic Drug Major Product Offerings
7.5.4 Novartis International AG Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.5.5 Novartis International AG Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Disease-Modifying Antirheumatic Drug Major Product Offerings
7.6.4 Johnson & Johnson Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Corporate Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Major Product Offerings
7.7.4 Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.7.5 Bristol-Myers Squibb Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Disease-Modifying Antirheumatic Drug Major Product Offerings
7.8.4 Merck Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.8.5 Merck Key News
7.9 UCB S.A.
7.9.1 UCB S.A. Corporate Summary
7.9.2 UCB S.A. Business Overview
7.9.3 UCB S.A. Disease-Modifying Antirheumatic Drug Major Product Offerings
7.9.4 UCB S.A. Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.9.5 UCB S.A. Key News
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Corporate Summary
7.10.2 Eli Lilly and Company Business Overview
7.10.3 Eli Lilly and Company Disease-Modifying Antirheumatic Drug Major Product Offerings
7.10.4 Eli Lilly and Company Disease-Modifying Antirheumatic Drug Sales and Revenue in Global (2017-2022)
7.10.5 Eli Lilly and Company Key News
8 GLOBAL DISEASE-MODIFYING ANTIRHEUMATIC DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global Disease-Modifying Antirheumatic Drug Production Capacity, 2017-2028
8.2 Disease-Modifying Antirheumatic Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Disease-Modifying Antirheumatic Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DISEASE-MODIFYING ANTIRHEUMATIC DRUG SUPPLY CHAIN ANALYSIS
10.1 Disease-Modifying Antirheumatic Drug Industry Value Chain
10.2 Disease-Modifying Antirheumatic Drug Upstream Market
10.3 Disease-Modifying Antirheumatic Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Disease-Modifying Antirheumatic Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Disease-Modifying Antirheumatic Drug in Global Market
Table 2. Top Disease-Modifying Antirheumatic Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Disease-Modifying Antirheumatic Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Disease-Modifying Antirheumatic Drug Revenue Share by Companies, 2017-2022
Table 5. Global Disease-Modifying Antirheumatic Drug Sales by Companies, (MT), 2017-2022
Table 6. Global Disease-Modifying Antirheumatic Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Disease-Modifying Antirheumatic Drug Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Disease-Modifying Antirheumatic Drug Product Type
Table 9. List of Global Tier 1 Disease-Modifying Antirheumatic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Disease-Modifying Antirheumatic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2017-2022
Table 15. By Type - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2023-2028
Table 16. By Application – Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2017-2022
Table 20. By Application - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2023-2028
Table 21. By Region – Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2017-2022
Table 25. By Region - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2023-2028
Table 26. By Country - North America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Disease-Modifying Antirheumatic Drug Sales, (MT), 2017-2022
Table 29. By Country - North America Disease-Modifying Antirheumatic Drug Sales, (MT), 2023-2028
Table 30. By Country - Europe Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Disease-Modifying Antirheumatic Drug Sales, (MT), 2017-2022
Table 33. By Country - Europe Disease-Modifying Antirheumatic Drug Sales, (MT), 2023-2028
Table 34. By Region - Asia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Disease-Modifying Antirheumatic Drug Sales, (MT), 2017-2022
Table 37. By Region - Asia Disease-Modifying Antirheumatic Drug Sales, (MT), 2023-2028
Table 38. By Country - South America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Disease-Modifying Antirheumatic Drug Sales, (MT), 2017-2022
Table 41. By Country - South America Disease-Modifying Antirheumatic Drug Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Sales, (MT), 2023-2028
Table 46. AbbVie Corporate Summary
Table 47. AbbVie Disease-Modifying Antirheumatic Drug Product Offerings
Table 48. AbbVie Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Amgen Corporate Summary
Table 50. Amgen Disease-Modifying Antirheumatic Drug Product Offerings
Table 51. Amgen Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Disease-Modifying Antirheumatic Drug Product Offerings
Table 54. Pfizer Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Roche Holding AG Corporate Summary
Table 56. Roche Holding AG Disease-Modifying Antirheumatic Drug Product Offerings
Table 57. Roche Holding AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Novartis International AG Corporate Summary
Table 59. Novartis International AG Disease-Modifying Antirheumatic Drug Product Offerings
Table 60. Novartis International AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson Disease-Modifying Antirheumatic Drug Product Offerings
Table 63. Johnson & Johnson Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Bristol-Myers Squibb Corporate Summary
Table 65. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Product Offerings
Table 66. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Merck Corporate Summary
Table 68. Merck Disease-Modifying Antirheumatic Drug Product Offerings
Table 69. Merck Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. UCB S.A. Corporate Summary
Table 71. UCB S.A. Disease-Modifying Antirheumatic Drug Product Offerings
Table 72. UCB S.A. Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Eli Lilly and Company Corporate Summary
Table 74. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Product Offerings
Table 75. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. Disease-Modifying Antirheumatic Drug Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 77. Global Disease-Modifying Antirheumatic Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Disease-Modifying Antirheumatic Drug Production by Region, 2017-2022 (MT)
Table 79. Global Disease-Modifying Antirheumatic Drug Production by Region, 2023-2028 (MT)
Table 80. Disease-Modifying Antirheumatic Drug Market Opportunities & Trends in Global Market
Table 81. Disease-Modifying Antirheumatic Drug Market Drivers in Global Market
Table 82. Disease-Modifying Antirheumatic Drug Market Restraints in Global Market
Table 83. Disease-Modifying Antirheumatic Drug Raw Materials
Table 84. Disease-Modifying Antirheumatic Drug Raw Materials Suppliers in Global Market
Table 85. Typical Disease-Modifying Antirheumatic Drug Downstream
Table 86. Disease-Modifying Antirheumatic Drug Downstream Clients in Global Market
Table 87. Disease-Modifying Antirheumatic Drug Distributors and Sales Agents in Global Market
Table 1. Key Players of Disease-Modifying Antirheumatic Drug in Global Market
Table 2. Top Disease-Modifying Antirheumatic Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Disease-Modifying Antirheumatic Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Disease-Modifying Antirheumatic Drug Revenue Share by Companies, 2017-2022
Table 5. Global Disease-Modifying Antirheumatic Drug Sales by Companies, (MT), 2017-2022
Table 6. Global Disease-Modifying Antirheumatic Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Disease-Modifying Antirheumatic Drug Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Disease-Modifying Antirheumatic Drug Product Type
Table 9. List of Global Tier 1 Disease-Modifying Antirheumatic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Disease-Modifying Antirheumatic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2017-2022
Table 15. By Type - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2023-2028
Table 16. By Application – Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2017-2022
Table 20. By Application - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2023-2028
Table 21. By Region – Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2017-2022
Table 25. By Region - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2023-2028
Table 26. By Country - North America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Disease-Modifying Antirheumatic Drug Sales, (MT), 2017-2022
Table 29. By Country - North America Disease-Modifying Antirheumatic Drug Sales, (MT), 2023-2028
Table 30. By Country - Europe Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Disease-Modifying Antirheumatic Drug Sales, (MT), 2017-2022
Table 33. By Country - Europe Disease-Modifying Antirheumatic Drug Sales, (MT), 2023-2028
Table 34. By Region - Asia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Disease-Modifying Antirheumatic Drug Sales, (MT), 2017-2022
Table 37. By Region - Asia Disease-Modifying Antirheumatic Drug Sales, (MT), 2023-2028
Table 38. By Country - South America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Disease-Modifying Antirheumatic Drug Sales, (MT), 2017-2022
Table 41. By Country - South America Disease-Modifying Antirheumatic Drug Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Sales, (MT), 2023-2028
Table 46. AbbVie Corporate Summary
Table 47. AbbVie Disease-Modifying Antirheumatic Drug Product Offerings
Table 48. AbbVie Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Amgen Corporate Summary
Table 50. Amgen Disease-Modifying Antirheumatic Drug Product Offerings
Table 51. Amgen Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Disease-Modifying Antirheumatic Drug Product Offerings
Table 54. Pfizer Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Roche Holding AG Corporate Summary
Table 56. Roche Holding AG Disease-Modifying Antirheumatic Drug Product Offerings
Table 57. Roche Holding AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Novartis International AG Corporate Summary
Table 59. Novartis International AG Disease-Modifying Antirheumatic Drug Product Offerings
Table 60. Novartis International AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson Disease-Modifying Antirheumatic Drug Product Offerings
Table 63. Johnson & Johnson Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Bristol-Myers Squibb Corporate Summary
Table 65. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Product Offerings
Table 66. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Merck Corporate Summary
Table 68. Merck Disease-Modifying Antirheumatic Drug Product Offerings
Table 69. Merck Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. UCB S.A. Corporate Summary
Table 71. UCB S.A. Disease-Modifying Antirheumatic Drug Product Offerings
Table 72. UCB S.A. Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Eli Lilly and Company Corporate Summary
Table 74. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Product Offerings
Table 75. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. Disease-Modifying Antirheumatic Drug Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 77. Global Disease-Modifying Antirheumatic Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Disease-Modifying Antirheumatic Drug Production by Region, 2017-2022 (MT)
Table 79. Global Disease-Modifying Antirheumatic Drug Production by Region, 2023-2028 (MT)
Table 80. Disease-Modifying Antirheumatic Drug Market Opportunities & Trends in Global Market
Table 81. Disease-Modifying Antirheumatic Drug Market Drivers in Global Market
Table 82. Disease-Modifying Antirheumatic Drug Market Restraints in Global Market
Table 83. Disease-Modifying Antirheumatic Drug Raw Materials
Table 84. Disease-Modifying Antirheumatic Drug Raw Materials Suppliers in Global Market
Table 85. Typical Disease-Modifying Antirheumatic Drug Downstream
Table 86. Disease-Modifying Antirheumatic Drug Downstream Clients in Global Market
Table 87. Disease-Modifying Antirheumatic Drug Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Disease-Modifying Antirheumatic Drug Segment by Type
Figure 2. Disease-Modifying Antirheumatic Drug Segment by Application
Figure 3. Global Disease-Modifying Antirheumatic Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Disease-Modifying Antirheumatic Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Disease-Modifying Antirheumatic Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Disease-Modifying Antirheumatic Drug Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Disease-Modifying Antirheumatic Drug Revenue in 2021
Figure 9. By Type - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Disease-Modifying Antirheumatic Drug Price (USD/MT), 2017-2028
Figure 12. By Application - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Disease-Modifying Antirheumatic Drug Price (USD/MT), 2017-2028
Figure 15. By Region - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 19. US Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 24. Germany Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 33. China Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 40. Brazil Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 44. Turkey Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Disease-Modifying Antirheumatic Drug Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Disease-Modifying Antirheumatic Drug by Region, 2021 VS 2028
Figure 50. Disease-Modifying Antirheumatic Drug Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Disease-Modifying Antirheumatic Drug Segment by Type
Figure 2. Disease-Modifying Antirheumatic Drug Segment by Application
Figure 3. Global Disease-Modifying Antirheumatic Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Disease-Modifying Antirheumatic Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Disease-Modifying Antirheumatic Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Disease-Modifying Antirheumatic Drug Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Disease-Modifying Antirheumatic Drug Revenue in 2021
Figure 9. By Type - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Disease-Modifying Antirheumatic Drug Price (USD/MT), 2017-2028
Figure 12. By Application - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Disease-Modifying Antirheumatic Drug Price (USD/MT), 2017-2028
Figure 15. By Region - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 19. US Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 24. Germany Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 33. China Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 40. Brazil Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Sales Market Share, 2017-2028
Figure 44. Turkey Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Disease-Modifying Antirheumatic Drug Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Disease-Modifying Antirheumatic Drug by Region, 2021 VS 2028
Figure 50. Disease-Modifying Antirheumatic Drug Industry Value Chain
Figure 51. Marketing Channels
